Linde plc

NasdaqGS:LIN Stock Report

Market Cap: US$211.4b

Linde Valuation

Is LIN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LIN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LIN ($450.14) is trading above our estimate of fair value ($342.25)

Significantly Below Fair Value: LIN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LIN?

Key metric: As LIN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LIN. This is calculated by dividing LIN's market cap by their current earnings.
What is LIN's PE Ratio?
PE Ratio33.6x
EarningsUS$6.38b
Market CapUS$211.44b

Price to Earnings Ratio vs Peers

How does LIN's PE Ratio compare to its peers?

The above table shows the PE ratio for LIN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average37.3x
APD Air Products and Chemicals
19x1.4%US$72.9b
SHW Sherwin-Williams
36.5x8.8%US$93.7b
ECL Ecolab
33.5x6.6%US$69.2b
CTVA Corteva
60.3x26.2%US$40.0b
LIN Linde
33.6x9.4%US$211.4b

Price-To-Earnings vs Peers: LIN is good value based on its Price-To-Earnings Ratio (33.6x) compared to the peer average (37.3x).

Price to Earnings Ratio vs Industry

How does LIN's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$9.40m
BON Bon Natural Life
2.4xn/aUS$5.36m
GSPI Green Star Products
1.7xn/aUS$1.49m
LIN 33.6xIndustry Avg. 23.2xNo. of Companies7PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LIN is expensive based on its Price-To-Earnings Ratio (33.6x) compared to the US Chemicals industry average (23.2x).

Price to Earnings Ratio vs Fair Ratio

What is LIN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LIN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio33.6x
Fair PE Ratio23.9x

Price-To-Earnings vs Fair Ratio: LIN is expensive based on its Price-To-Earnings Ratio (33.6x) compared to the estimated Fair Price-To-Earnings Ratio (23.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LIN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$450.14
US$493.97
+9.7%
7.9%US$550.00US$381.00n/a25
Nov ’25US$457.31
US$493.17
+7.8%
7.8%US$550.00US$381.00n/a25
Oct ’25US$475.02
US$485.29
+2.2%
7.8%US$550.00US$381.00n/a25
Sep ’25US$478.25
US$487.19
+1.9%
7.3%US$550.00US$381.00n/a25
Aug ’25US$453.34
US$473.63
+4.5%
7.2%US$540.00US$381.00n/a25
Jul ’25US$428.94
US$472.83
+10.2%
7.3%US$540.00US$381.00n/a25
Jun ’25US$435.52
US$470.11
+7.9%
7.2%US$540.00US$381.00n/a25
May ’25US$442.62
US$472.57
+6.8%
8.7%US$540.00US$347.00n/a25
Apr ’25US$463.40
US$466.73
+0.7%
8.7%US$525.00US$347.00n/a25
Mar ’25US$449.21
US$453.73
+1.0%
7.1%US$501.19US$347.00n/a25
Feb ’25US$408.65
US$440.31
+7.7%
6.8%US$480.00US$347.00n/a25
Jan ’25US$410.71
US$433.88
+5.6%
6.2%US$480.00US$347.00n/a26
Dec ’24US$411.70
US$427.34
+3.8%
5.5%US$480.00US$347.00n/a26
Nov ’24US$387.10
US$420.82
+8.7%
5.4%US$450.00US$347.00US$457.3128
Oct ’24US$372.35
US$417.34
+12.1%
6.0%US$450.00US$339.00US$475.0228
Sep ’24US$388.91
US$418.59
+7.6%
6.0%US$450.00US$339.00US$478.2528
Aug ’24US$388.64
US$416.75
+7.2%
5.8%US$450.00US$339.00US$453.3428
Jul ’24US$381.08
US$400.90
+5.2%
5.0%US$430.00US$339.00US$428.9428
Jun ’24US$355.49
US$399.82
+12.5%
4.9%US$430.00US$339.00US$435.5227
May ’24US$372.31
US$394.85
+6.1%
4.4%US$430.00US$365.00US$442.6226
Apr ’24US$355.44
US$377.00
+6.1%
4.5%US$412.00US$335.00US$463.4024
Mar ’24US$350.05
US$376.04
+7.4%
4.2%US$418.00US$335.00US$449.2123
Feb ’24US$331.08
US$364.09
+10.0%
4.5%US$402.00US$335.00US$408.6523
Jan ’24US$326.18
US$357.23
+9.5%
7.3%US$402.00US$260.00US$410.7122
Dec ’23US$337.26
US$349.18
+3.5%
6.9%US$380.00US$260.00US$411.7022
Nov ’23US$298.17
US$348.50
+16.9%
7.4%US$390.00US$260.00US$387.1022

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Trinseo

US$117.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.25

7D

-10.2%

1Y

-49.9%

Huntsman

US$3.3b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.42

7D

-1.3%

1Y

-22.1%

CMOC Group

HK$166.5b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.77

7D

1.7%

1Y

40.1%